Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1991;11:1652-1659

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demacker, P. N.
Right arrow Articles by Auwerx, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demacker, P. N.
Right arrow Articles by Auwerx, J.

Arteriosclerosis and Thrombosis, Vol 11, 1652-1659, Copyright © 1991 by American Heart Association


ARTICLES

Increased removal of beta-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase, and the low density lipoprotein receptor in Watanabe heritable hyperlipidemic rabbits

PN Demacker, B Staels, AF Stalenhoef and J Auwerx
Department of Medicine, University Hospital, Nijmegen, The Netherlands.

The mechanism by which ethinyl estradiol (EE) decreases the concentration of lipids in the d less than 1.019 g/ml fraction (beta- very low density lipoprotein [beta-VLDL]) of homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits was studied. Treatment with EE increased the activity of hepatic lipase (HL) twofold to threefold in postheparin plasma and in liver biopsies. Postheparin plasma and adipose tissue lipoprotein lipase (LPL) activities were also increased twofold to fourfold after EE. The effects of EE on HL and LPL activities were associated with a threefold to sixfold elevation in liver HL mRNA and a fourfold elevation in adipose tissue LPL mRNA steady-state levels, pointing to an effect of EE on HL and LPL gene transcription. EE also increased liver low density lipoprotein (LDL) receptor mRNA levels threefold to fivefold. These results suggest a concerted action of LPL, HL, and the LDL receptor in the removal of beta-VLDL in homozygous WHHL rabbits with a defective LDL receptor. In addition, the content of apolipoprotein E in the d less than 1.019 g/ml fraction changed toward normal after EE. Because the remaining particles contained apolipoprotein B-100 almost exclusively, it is likely that apolipoprotein E-containing beta-VLDLs are preferentially removed. This may be the result of the increased activity of LPL and HL influencing the conformation of apolipoprotein E on the beta-VLDL particle in such a way that it is directly removed from the circulation, possibly by the induced LDL receptor.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
D. M. Attia, R. Goldschmeding, M. A. Attia, P. Boer, H. A. Koomans, and J. A. Joles
Male gender increases sensitivity to renal injury in response to cholesterol loading
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F718 - F726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. K. Dubey and E. K. Jackson
Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms
Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Huang, S. W. Schwendner, S. C. Rall Jr., D. A. Sanan, and R. W. Mahley
Apolipoprotein E2 Transgenic Rabbits. MODULATION OF THE TYPE III HYPERLIPOPROTEINEMIC PHENOTYPE BY ESTROGEN AND OCCURRENCE OF SPONTANEOUS ATHEROSCLEROSIS
J. Biol. Chem., September 5, 1997; 272(36): 22685 - 22694.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Masuzaki, H. Jingami, N. Matsuoka, O. Nakagawa, Y. Ogawa, M. Mizuno, Y. Yoshimasa, T. Yamamoto, and K. Nakao
Regulation of Very-Low-Density Lipoprotein Receptor in Hypertrophic Rat Heart
Circ. Res., January 1, 1996; 78(1): 8 - 14.
[Abstract] [Full Text]